Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults

Background Cardiovascular disease (CVD) is a leading cause of death in the US population. Lead exposure is an important risk factor of CVDs, as is associated with elevated homocysteine level and oxidative stress. We aim to examine whether vitamin B6, which has been shown to reduce homocysteine level...

Full description

Bibliographic Details
Main Authors: John S Ji, Jia Wei
Format: Article
Language:English
Published: BMJ Publishing Group
Series:BMJ Nutrition, Prevention & Health
Online Access:https://nutrition.bmj.com/content/early/2020/08/12/bmjnph-2020-000088.full
id doaj-5d291c1ff74d46eeafb8a6b678a4c526
record_format Article
spelling doaj-5d291c1ff74d46eeafb8a6b678a4c5262020-11-25T04:01:30ZengBMJ Publishing GroupBMJ Nutrition, Prevention & Health2516-554210.1136/bmjnph-2020-000088Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adultsJohn S Ji0Jia Wei1Environmental Research Center, Duke Kunshan University, Kunshan, ChinaDepartment of Pediatric Surgery, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaBackground Cardiovascular disease (CVD) is a leading cause of death in the US population. Lead exposure is an important risk factor of CVDs, as is associated with elevated homocysteine level and oxidative stress. We aim to examine whether vitamin B6, which has been shown to reduce homocysteine level, can modify the relationship between blood lead and the risk of CVDs.Methods Cross-sectional data on ever-report CVDs (congestive heart failure, coronary heart disease, angina pectoris, heart attack and stroke), blood lead level (BLL) and vitamin B6 in the form of plasma pyridoxal 5'-phosphate were obtained from US National Health and Nutrition Examination Survey 2005–2006 for adults≥20 years old. The association between CVDs and quartiles of BLL was estimated using multivariate logistic regression models adjusted for demographics factors, lifestyle variables, stress variables, comorbidities and CVD biomarkers (C reactive protein, homocysteine, cholesterol) and was stratified by vitamin B6 deficiency level (<20 nmol/L) and median value of vitamin B6 (42.5 nmol/L).Results Positive associations between BLL and CVDs only appeared in the vitamin B6 deficiency group, with quartile 2 to quartile 4 of BLL showing higher risk of CVDs (OR=3.1, 95% CI 0.9 to 10.6; OR=6.5, 95% CI 1.4 to 30.8; OR=5.5, 95% CI 1.4 to 21.7) compared with quartile 1. When stratified by median value of vitamin B6, a significant association between higher CVD risk with higher BLL was only observed in subjects with low vitamin B6 (p trend=0.004).Conclusions Vitamin B6 could modify the association between BLL and CVDs, which suggests a potential value of vitamin B6 in influencing the effects of lead exposure on the cardiovascular system.https://nutrition.bmj.com/content/early/2020/08/12/bmjnph-2020-000088.full
collection DOAJ
language English
format Article
sources DOAJ
author John S Ji
Jia Wei
spellingShingle John S Ji
Jia Wei
Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults
BMJ Nutrition, Prevention & Health
author_facet John S Ji
Jia Wei
author_sort John S Ji
title Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults
title_short Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults
title_full Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults
title_fullStr Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults
title_full_unstemmed Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults
title_sort modification of vitamin b6 on the associations of blood lead levels and cardiovascular diseases in the us adults
publisher BMJ Publishing Group
series BMJ Nutrition, Prevention & Health
issn 2516-5542
description Background Cardiovascular disease (CVD) is a leading cause of death in the US population. Lead exposure is an important risk factor of CVDs, as is associated with elevated homocysteine level and oxidative stress. We aim to examine whether vitamin B6, which has been shown to reduce homocysteine level, can modify the relationship between blood lead and the risk of CVDs.Methods Cross-sectional data on ever-report CVDs (congestive heart failure, coronary heart disease, angina pectoris, heart attack and stroke), blood lead level (BLL) and vitamin B6 in the form of plasma pyridoxal 5'-phosphate were obtained from US National Health and Nutrition Examination Survey 2005–2006 for adults≥20 years old. The association between CVDs and quartiles of BLL was estimated using multivariate logistic regression models adjusted for demographics factors, lifestyle variables, stress variables, comorbidities and CVD biomarkers (C reactive protein, homocysteine, cholesterol) and was stratified by vitamin B6 deficiency level (<20 nmol/L) and median value of vitamin B6 (42.5 nmol/L).Results Positive associations between BLL and CVDs only appeared in the vitamin B6 deficiency group, with quartile 2 to quartile 4 of BLL showing higher risk of CVDs (OR=3.1, 95% CI 0.9 to 10.6; OR=6.5, 95% CI 1.4 to 30.8; OR=5.5, 95% CI 1.4 to 21.7) compared with quartile 1. When stratified by median value of vitamin B6, a significant association between higher CVD risk with higher BLL was only observed in subjects with low vitamin B6 (p trend=0.004).Conclusions Vitamin B6 could modify the association between BLL and CVDs, which suggests a potential value of vitamin B6 in influencing the effects of lead exposure on the cardiovascular system.
url https://nutrition.bmj.com/content/early/2020/08/12/bmjnph-2020-000088.full
work_keys_str_mv AT johnsji modificationofvitaminb6ontheassociationsofbloodleadlevelsandcardiovasculardiseasesintheusadults
AT jiawei modificationofvitaminb6ontheassociationsofbloodleadlevelsandcardiovasculardiseasesintheusadults
_version_ 1724446675192250368